nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—ABCB1—Methylprednisolone—psoriatic arthritis	0.0657	0.279	CbGbCtD
Trifluoperazine—S100A4—synovial membrane of synovial joint—psoriatic arthritis	0.0443	0.494	CbGeAlD
Trifluoperazine—ABCB1—Betamethasone—psoriatic arthritis	0.0428	0.182	CbGbCtD
Trifluoperazine—ABCB1—Prednisolone—psoriatic arthritis	0.0422	0.179	CbGbCtD
Trifluoperazine—ABCB1—Prednisone—psoriatic arthritis	0.0398	0.169	CbGbCtD
Trifluoperazine—ABCB1—Dexamethasone—psoriatic arthritis	0.0249	0.106	CbGbCtD
Trifluoperazine—Pigmentation skin—Prednisone—psoriatic arthritis	0.0218	0.0345	CcSEcCtD
Trifluoperazine—Megacolon—Methotrexate—psoriatic arthritis	0.0202	0.0321	CcSEcCtD
Trifluoperazine—ABCB1—Methotrexate—psoriatic arthritis	0.02	0.0849	CbGbCtD
Trifluoperazine—Aplastic anaemia—Auranofin—psoriatic arthritis	0.0161	0.0255	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Auranofin—psoriatic arthritis	0.0132	0.0209	CcSEcCtD
Trifluoperazine—Pigmentation disorder—Prednisone—psoriatic arthritis	0.0119	0.0189	CcSEcCtD
Trifluoperazine—Dysphagia—Auranofin—psoriatic arthritis	0.0108	0.017	CcSEcCtD
Trifluoperazine—Eosinophilia—Auranofin—psoriatic arthritis	0.0107	0.0169	CcSEcCtD
Trifluoperazine—Pancytopenia—Auranofin—psoriatic arthritis	0.0102	0.0162	CcSEcCtD
Trifluoperazine—Menstruation irregular—Prednisolone—psoriatic arthritis	0.00988	0.0157	CcSEcCtD
Trifluoperazine—Jaundice—Auranofin—psoriatic arthritis	0.00936	0.0148	CcSEcCtD
Trifluoperazine—Retinal disorder—Methotrexate—psoriatic arthritis	0.00931	0.0147	CcSEcCtD
Trifluoperazine—Menstruation irregular—Triamcinolone—psoriatic arthritis	0.00909	0.0144	CcSEcCtD
Trifluoperazine—Systemic lupus erythematosus—Triamcinolone—psoriatic arthritis	0.00909	0.0144	CcSEcCtD
Trifluoperazine—Menstruation irregular—Methylprednisolone—psoriatic arthritis	0.00907	0.0144	CcSEcCtD
Trifluoperazine—Agranulocytosis—Auranofin—psoriatic arthritis	0.00896	0.0142	CcSEcCtD
Trifluoperazine—S100A4—skin of body—psoriatic arthritis	0.00881	0.0982	CbGeAlD
Trifluoperazine—Menstruation irregular—Betamethasone—psoriatic arthritis	0.00825	0.0131	CcSEcCtD
Trifluoperazine—Menstruation irregular—Dexamethasone—psoriatic arthritis	0.00825	0.0131	CcSEcCtD
Trifluoperazine—HTR2A—vertebral column—psoriatic arthritis	0.0081	0.0902	CbGeAlD
Trifluoperazine—S100A4—Desoximetasone—Methylprednisolone—psoriatic arthritis	0.00757	0.174	CbGdCrCtD
Trifluoperazine—S100A4—Desoximetasone—Dexamethasone—psoriatic arthritis	0.00745	0.172	CbGdCrCtD
Trifluoperazine—S100A4—Desoximetasone—Betamethasone—psoriatic arthritis	0.00745	0.172	CbGdCrCtD
Trifluoperazine—S100A4—Desoximetasone—Triamcinolone—psoriatic arthritis	0.00728	0.168	CbGdCrCtD
Trifluoperazine—Menstruation irregular—Prednisone—psoriatic arthritis	0.00718	0.0114	CcSEcCtD
Trifluoperazine—S100A4—Desoximetasone—Prednisone—psoriatic arthritis	0.00691	0.159	CbGdCrCtD
Trifluoperazine—Mydriasis—Prednisolone—psoriatic arthritis	0.00686	0.0109	CcSEcCtD
Trifluoperazine—Angioedema—Auranofin—psoriatic arthritis	0.00686	0.0109	CcSEcCtD
Trifluoperazine—S100A4—Desoximetasone—Prednisolone—psoriatic arthritis	0.00674	0.155	CbGdCrCtD
Trifluoperazine—Leukopenia—Auranofin—psoriatic arthritis	0.00672	0.0106	CcSEcCtD
Trifluoperazine—S100A4—tendon—psoriatic arthritis	0.00671	0.0748	CbGeAlD
Trifluoperazine—Sudden death—Methotrexate—psoriatic arthritis	0.00649	0.0103	CcSEcCtD
Trifluoperazine—Glycosuria—Triamcinolone—psoriatic arthritis	0.00621	0.00984	CcSEcCtD
Trifluoperazine—Glycosuria—Methylprednisolone—psoriatic arthritis	0.0062	0.00981	CcSEcCtD
Trifluoperazine—Anorexia—Auranofin—psoriatic arthritis	0.00584	0.00924	CcSEcCtD
Trifluoperazine—Amenorrhoea—Methylprednisolone—psoriatic arthritis	0.00571	0.00905	CcSEcCtD
Trifluoperazine—TNNC1—tendon—psoriatic arthritis	0.00565	0.0629	CbGeAlD
Trifluoperazine—Glycosuria—Betamethasone—psoriatic arthritis	0.00564	0.00892	CcSEcCtD
Trifluoperazine—Glycosuria—Dexamethasone—psoriatic arthritis	0.00564	0.00892	CcSEcCtD
Trifluoperazine—Decreased appetite—Auranofin—psoriatic arthritis	0.00532	0.00843	CcSEcCtD
Trifluoperazine—Constipation—Auranofin—psoriatic arthritis	0.00524	0.00829	CcSEcCtD
Trifluoperazine—Amenorrhoea—Betamethasone—psoriatic arthritis	0.0052	0.00823	CcSEcCtD
Trifluoperazine—Amenorrhoea—Dexamethasone—psoriatic arthritis	0.0052	0.00823	CcSEcCtD
Trifluoperazine—Glycosuria—Prednisone—psoriatic arthritis	0.00491	0.00777	CcSEcCtD
Trifluoperazine—Urticaria—Auranofin—psoriatic arthritis	0.00486	0.0077	CcSEcCtD
Trifluoperazine—Amenorrhoea—Prednisone—psoriatic arthritis	0.00453	0.00717	CcSEcCtD
Trifluoperazine—Pruritus—Auranofin—psoriatic arthritis	0.00433	0.00686	CcSEcCtD
Trifluoperazine—Increased appetite—Prednisolone—psoriatic arthritis	0.00423	0.00669	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Prednisolone—psoriatic arthritis	0.0041	0.0065	CcSEcCtD
Trifluoperazine—Increased appetite—Triamcinolone—psoriatic arthritis	0.00389	0.00616	CcSEcCtD
Trifluoperazine—Increased appetite—Methylprednisolone—psoriatic arthritis	0.00388	0.00614	CcSEcCtD
Trifluoperazine—Rash—Auranofin—psoriatic arthritis	0.00386	0.00611	CcSEcCtD
Trifluoperazine—Dermatitis—Auranofin—psoriatic arthritis	0.00386	0.00611	CcSEcCtD
Trifluoperazine—Cardiac arrest—Prednisolone—psoriatic arthritis	0.00378	0.00598	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Triamcinolone—psoriatic arthritis	0.00377	0.00598	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Methylprednisolone—psoriatic arthritis	0.00377	0.00596	CcSEcCtD
Trifluoperazine—Nausea—Auranofin—psoriatic arthritis	0.00364	0.00576	CcSEcCtD
Trifluoperazine—Increased appetite—Betamethasone—psoriatic arthritis	0.00353	0.00559	CcSEcCtD
Trifluoperazine—Increased appetite—Dexamethasone—psoriatic arthritis	0.00353	0.00559	CcSEcCtD
Trifluoperazine—Muscular weakness—Prednisolone—psoriatic arthritis	0.0035	0.00555	CcSEcCtD
Trifluoperazine—Cardiac arrest—Triamcinolone—psoriatic arthritis	0.00347	0.0055	CcSEcCtD
Trifluoperazine—Cardiac arrest—Methylprednisolone—psoriatic arthritis	0.00347	0.00549	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Betamethasone—psoriatic arthritis	0.00342	0.00542	CcSEcCtD
Trifluoperazine—Anaphylactoid reaction—Dexamethasone—psoriatic arthritis	0.00342	0.00542	CcSEcCtD
Trifluoperazine—Muscular weakness—Triamcinolone—psoriatic arthritis	0.00322	0.0051	CcSEcCtD
Trifluoperazine—Muscular weakness—Methylprednisolone—psoriatic arthritis	0.00321	0.00509	CcSEcCtD
Trifluoperazine—Asthma—Triamcinolone—psoriatic arthritis	0.00316	0.005	CcSEcCtD
Trifluoperazine—Cardiac arrest—Dexamethasone—psoriatic arthritis	0.00315	0.00499	CcSEcCtD
Trifluoperazine—Cardiac arrest—Betamethasone—psoriatic arthritis	0.00315	0.00499	CcSEcCtD
Trifluoperazine—Weight increased—Prednisolone—psoriatic arthritis	0.00312	0.00495	CcSEcCtD
Trifluoperazine—Aplastic anaemia—Methotrexate—psoriatic arthritis	0.00312	0.00494	CcSEcCtD
Trifluoperazine—Bronchospasm—Methylprednisolone—psoriatic arthritis	0.0031	0.00491	CcSEcCtD
Trifluoperazine—Increased appetite—Prednisone—psoriatic arthritis	0.00307	0.00486	CcSEcCtD
Trifluoperazine—Gynaecomastia—Methotrexate—psoriatic arthritis	0.00297	0.00471	CcSEcCtD
Trifluoperazine—Muscular weakness—Dexamethasone—psoriatic arthritis	0.00292	0.00463	CcSEcCtD
Trifluoperazine—Muscular weakness—Betamethasone—psoriatic arthritis	0.00292	0.00463	CcSEcCtD
Trifluoperazine—Weight increased—Triamcinolone—psoriatic arthritis	0.00287	0.00455	CcSEcCtD
Trifluoperazine—Weight increased—Methylprednisolone—psoriatic arthritis	0.00287	0.00454	CcSEcCtD
Trifluoperazine—Photosensitivity—Methotrexate—psoriatic arthritis	0.00275	0.00435	CcSEcCtD
Trifluoperazine—Cardiac arrest—Prednisone—psoriatic arthritis	0.00274	0.00435	CcSEcCtD
Trifluoperazine—Weight increased—Dexamethasone—psoriatic arthritis	0.00261	0.00413	CcSEcCtD
Trifluoperazine—Weight increased—Betamethasone—psoriatic arthritis	0.00261	0.00413	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.00258	0.00409	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.00258	0.00409	CcSEcCtD
Trifluoperazine—Dermatitis exfoliative—Methotrexate—psoriatic arthritis	0.00256	0.00405	CcSEcCtD
Trifluoperazine—Muscular weakness—Prednisone—psoriatic arthritis	0.00255	0.00403	CcSEcCtD
Trifluoperazine—CALM2—skin of body—psoriatic arthritis	0.00254	0.0283	CbGeAlD
Trifluoperazine—CALM1—skin of body—psoriatic arthritis	0.00253	0.0281	CbGeAlD
Trifluoperazine—Anaphylactoid reaction—Methotrexate—psoriatic arthritis	0.00249	0.00395	CcSEcCtD
Trifluoperazine—CALM3—tendon—psoriatic arthritis	0.00246	0.0274	CbGeAlD
Trifluoperazine—Erythema—Prednisolone—psoriatic arthritis	0.00239	0.00379	CcSEcCtD
Trifluoperazine—Erectile dysfunction—Prednisone—psoriatic arthritis	0.0023	0.00364	CcSEcCtD
Trifluoperazine—Weight increased—Prednisone—psoriatic arthritis	0.00227	0.0036	CcSEcCtD
Trifluoperazine—Vision blurred—Prednisolone—psoriatic arthritis	0.00225	0.00357	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Prednisone—psoriatic arthritis	0.00225	0.00356	CcSEcCtD
Trifluoperazine—Erythema—Triamcinolone—psoriatic arthritis	0.0022	0.00348	CcSEcCtD
Trifluoperazine—SIGMAR1—tendon—psoriatic arthritis	0.0022	0.0245	CbGeAlD
Trifluoperazine—Erythema—Methylprednisolone—psoriatic arthritis	0.0022	0.00348	CcSEcCtD
Trifluoperazine—Angioedema—Prednisolone—psoriatic arthritis	0.00219	0.00346	CcSEcCtD
Trifluoperazine—Asthma—Methotrexate—psoriatic arthritis	0.00209	0.0033	CcSEcCtD
Trifluoperazine—Convulsion—Prednisolone—psoriatic arthritis	0.00207	0.00328	CcSEcCtD
Trifluoperazine—Eosinophilia—Methotrexate—psoriatic arthritis	0.00206	0.00327	CcSEcCtD
Trifluoperazine—Angioedema—Triamcinolone—psoriatic arthritis	0.00201	0.00318	CcSEcCtD
Trifluoperazine—Angioedema—Methylprednisolone—psoriatic arthritis	0.00201	0.00318	CcSEcCtD
Trifluoperazine—Erythema—Dexamethasone—psoriatic arthritis	0.002	0.00316	CcSEcCtD
Trifluoperazine—Erythema—Betamethasone—psoriatic arthritis	0.002	0.00316	CcSEcCtD
Trifluoperazine—Pancytopenia—Methotrexate—psoriatic arthritis	0.00198	0.00314	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00195	0.00309	CcSEcCtD
Trifluoperazine—CALM2—tendon—psoriatic arthritis	0.00193	0.0215	CbGeAlD
Trifluoperazine—CALM1—tendon—psoriatic arthritis	0.00192	0.0214	CbGeAlD
Trifluoperazine—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.00192	0.00304	CcSEcCtD
Trifluoperazine—Cough—Triamcinolone—psoriatic arthritis	0.00192	0.00304	CcSEcCtD
Trifluoperazine—Convulsion—Triamcinolone—psoriatic arthritis	0.00191	0.00302	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.0019	0.00301	CcSEcCtD
Trifluoperazine—Convulsion—Methylprednisolone—psoriatic arthritis	0.0019	0.00301	CcSEcCtD
Trifluoperazine—Drowsiness—Methotrexate—psoriatic arthritis	0.00186	0.00294	CcSEcCtD
Trifluoperazine—Dry mouth—Triamcinolone—psoriatic arthritis	0.00183	0.0029	CcSEcCtD
Trifluoperazine—Angioedema—Betamethasone—psoriatic arthritis	0.00182	0.00289	CcSEcCtD
Trifluoperazine—Angioedema—Dexamethasone—psoriatic arthritis	0.00182	0.00289	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.0018	0.00284	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00179	0.00284	CcSEcCtD
Trifluoperazine—Insomnia—Prednisolone—psoriatic arthritis	0.00177	0.0028	CcSEcCtD
Trifluoperazine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00174	0.00276	CcSEcCtD
Trifluoperazine—Erythema—Prednisone—psoriatic arthritis	0.00174	0.00275	CcSEcCtD
Trifluoperazine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00173	0.00275	CcSEcCtD
Trifluoperazine—Convulsion—Betamethasone—psoriatic arthritis	0.00173	0.00274	CcSEcCtD
Trifluoperazine—Convulsion—Dexamethasone—psoriatic arthritis	0.00173	0.00274	CcSEcCtD
Trifluoperazine—Hypotension—Methylprednisolone—psoriatic arthritis	0.00167	0.00265	CcSEcCtD
Trifluoperazine—Vision blurred—Prednisone—psoriatic arthritis	0.00164	0.00259	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00163	0.00258	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00163	0.00258	CcSEcCtD
Trifluoperazine—Insomnia—Triamcinolone—psoriatic arthritis	0.00162	0.00257	CcSEcCtD
Trifluoperazine—Insomnia—Methylprednisolone—psoriatic arthritis	0.00162	0.00257	CcSEcCtD
Trifluoperazine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.0016	0.00253	CcSEcCtD
Trifluoperazine—Agitation—Prednisone—psoriatic arthritis	0.0016	0.00253	CcSEcCtD
Trifluoperazine—Angioedema—Prednisone—psoriatic arthritis	0.00159	0.00252	CcSEcCtD
Trifluoperazine—Anorexia—Dexamethasone—psoriatic arthritis	0.00155	0.00246	CcSEcCtD
Trifluoperazine—Anorexia—Betamethasone—psoriatic arthritis	0.00155	0.00246	CcSEcCtD
Trifluoperazine—Urticaria—Prednisolone—psoriatic arthritis	0.00155	0.00246	CcSEcCtD
Trifluoperazine—Fatigue—Triamcinolone—psoriatic arthritis	0.00155	0.00245	CcSEcCtD
Trifluoperazine—Fatigue—Methylprednisolone—psoriatic arthritis	0.00154	0.00245	CcSEcCtD
Trifluoperazine—Hypotension—Betamethasone—psoriatic arthritis	0.00152	0.00241	CcSEcCtD
Trifluoperazine—Hypotension—Dexamethasone—psoriatic arthritis	0.00152	0.00241	CcSEcCtD
Trifluoperazine—Convulsion—Prednisone—psoriatic arthritis	0.00151	0.00238	CcSEcCtD
Trifluoperazine—Insomnia—Dexamethasone—psoriatic arthritis	0.00147	0.00233	CcSEcCtD
Trifluoperazine—Insomnia—Betamethasone—psoriatic arthritis	0.00147	0.00233	CcSEcCtD
Trifluoperazine—Erythema—Methotrexate—psoriatic arthritis	0.00145	0.0023	CcSEcCtD
Trifluoperazine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00144	0.00228	CcSEcCtD
Trifluoperazine—Urticaria—Triamcinolone—psoriatic arthritis	0.00143	0.00226	CcSEcCtD
Trifluoperazine—Urticaria—Methylprednisolone—psoriatic arthritis	0.00142	0.00225	CcSEcCtD
Trifluoperazine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00142	0.00225	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00142	0.00225	CcSEcCtD
Trifluoperazine—Decreased appetite—Betamethasone—psoriatic arthritis	0.00142	0.00224	CcSEcCtD
Trifluoperazine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00142	0.00224	CcSEcCtD
Trifluoperazine—Fatigue—Dexamethasone—psoriatic arthritis	0.0014	0.00222	CcSEcCtD
Trifluoperazine—Fatigue—Betamethasone—psoriatic arthritis	0.0014	0.00222	CcSEcCtD
Trifluoperazine—HRH1—tendon—psoriatic arthritis	0.0014	0.0156	CbGeAlD
Trifluoperazine—Skin disorder—Prednisone—psoriatic arthritis	0.00138	0.00218	CcSEcCtD
Trifluoperazine—Vision blurred—Methotrexate—psoriatic arthritis	0.00137	0.00217	CcSEcCtD
Trifluoperazine—Anorexia—Prednisone—psoriatic arthritis	0.00135	0.00214	CcSEcCtD
Trifluoperazine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00132	0.00209	CcSEcCtD
Trifluoperazine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00132	0.00209	CcSEcCtD
Trifluoperazine—Leukopenia—Methotrexate—psoriatic arthritis	0.0013	0.00206	CcSEcCtD
Trifluoperazine—Urticaria—Betamethasone—psoriatic arthritis	0.00129	0.00205	CcSEcCtD
Trifluoperazine—Urticaria—Dexamethasone—psoriatic arthritis	0.00129	0.00205	CcSEcCtD
Trifluoperazine—Dizziness—Prednisolone—psoriatic arthritis	0.00129	0.00204	CcSEcCtD
Trifluoperazine—Asthenia—Triamcinolone—psoriatic arthritis	0.00129	0.00204	CcSEcCtD
Trifluoperazine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00129	0.00204	CcSEcCtD
Trifluoperazine—Body temperature increased—Betamethasone—psoriatic arthritis	0.00129	0.00204	CcSEcCtD
Trifluoperazine—Asthenia—Methylprednisolone—psoriatic arthritis	0.00129	0.00204	CcSEcCtD
Trifluoperazine—Insomnia—Prednisone—psoriatic arthritis	0.00128	0.00203	CcSEcCtD
Trifluoperazine—Pruritus—Triamcinolone—psoriatic arthritis	0.00127	0.00201	CcSEcCtD
Trifluoperazine—Cough—Methotrexate—psoriatic arthritis	0.00127	0.00201	CcSEcCtD
Trifluoperazine—Pruritus—Methylprednisolone—psoriatic arthritis	0.00127	0.00201	CcSEcCtD
Trifluoperazine—Convulsion—Methotrexate—psoriatic arthritis	0.00126	0.00199	CcSEcCtD
Trifluoperazine—Decreased appetite—Prednisone—psoriatic arthritis	0.00123	0.00195	CcSEcCtD
Trifluoperazine—Rash—Prednisolone—psoriatic arthritis	0.00123	0.00195	CcSEcCtD
Trifluoperazine—Dermatitis—Prednisolone—psoriatic arthritis	0.00123	0.00195	CcSEcCtD
Trifluoperazine—Fatigue—Prednisone—psoriatic arthritis	0.00122	0.00194	CcSEcCtD
Trifluoperazine—Headache—Prednisolone—psoriatic arthritis	0.00122	0.00194	CcSEcCtD
Trifluoperazine—Constipation—Prednisone—psoriatic arthritis	0.00121	0.00192	CcSEcCtD
Trifluoperazine—Dizziness—Triamcinolone—psoriatic arthritis	0.00119	0.00188	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00119	0.00188	CcSEcCtD
Trifluoperazine—Dizziness—Methylprednisolone—psoriatic arthritis	0.00118	0.00188	CcSEcCtD
Trifluoperazine—HTR2A—tendon—psoriatic arthritis	0.00117	0.013	CbGeAlD
Trifluoperazine—Asthenia—Dexamethasone—psoriatic arthritis	0.00117	0.00185	CcSEcCtD
Trifluoperazine—Asthenia—Betamethasone—psoriatic arthritis	0.00117	0.00185	CcSEcCtD
Trifluoperazine—Nausea—Prednisolone—psoriatic arthritis	0.00116	0.00184	CcSEcCtD
Trifluoperazine—Pruritus—Dexamethasone—psoriatic arthritis	0.00115	0.00183	CcSEcCtD
Trifluoperazine—Pruritus—Betamethasone—psoriatic arthritis	0.00115	0.00183	CcSEcCtD
Trifluoperazine—Skin disorder—Methotrexate—psoriatic arthritis	0.00115	0.00182	CcSEcCtD
Trifluoperazine—Rash—Triamcinolone—psoriatic arthritis	0.00113	0.00179	CcSEcCtD
Trifluoperazine—Dermatitis—Triamcinolone—psoriatic arthritis	0.00113	0.00179	CcSEcCtD
Trifluoperazine—Anorexia—Methotrexate—psoriatic arthritis	0.00113	0.00179	CcSEcCtD
Trifluoperazine—Rash—Methylprednisolone—psoriatic arthritis	0.00113	0.00179	CcSEcCtD
Trifluoperazine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00113	0.00179	CcSEcCtD
Trifluoperazine—Urticaria—Prednisone—psoriatic arthritis	0.00113	0.00178	CcSEcCtD
Trifluoperazine—Headache—Triamcinolone—psoriatic arthritis	0.00112	0.00178	CcSEcCtD
Trifluoperazine—Headache—Methylprednisolone—psoriatic arthritis	0.00112	0.00178	CcSEcCtD
Trifluoperazine—Body temperature increased—Prednisone—psoriatic arthritis	0.00112	0.00178	CcSEcCtD
Trifluoperazine—Hypotension—Methotrexate—psoriatic arthritis	0.00111	0.00175	CcSEcCtD
Trifluoperazine—Dizziness—Betamethasone—psoriatic arthritis	0.00108	0.00171	CcSEcCtD
Trifluoperazine—Dizziness—Dexamethasone—psoriatic arthritis	0.00108	0.00171	CcSEcCtD
Trifluoperazine—Insomnia—Methotrexate—psoriatic arthritis	0.00107	0.0017	CcSEcCtD
Trifluoperazine—Nausea—Triamcinolone—psoriatic arthritis	0.00107	0.00169	CcSEcCtD
Trifluoperazine—Nausea—Methylprednisolone—psoriatic arthritis	0.00106	0.00168	CcSEcCtD
Trifluoperazine—Dyspnoea—Methotrexate—psoriatic arthritis	0.00106	0.00167	CcSEcCtD
Trifluoperazine—Somnolence—Methotrexate—psoriatic arthritis	0.00105	0.00167	CcSEcCtD
Trifluoperazine—Hypersensitivity—Prednisone—psoriatic arthritis	0.00105	0.00166	CcSEcCtD
Trifluoperazine—Decreased appetite—Methotrexate—psoriatic arthritis	0.00103	0.00163	CcSEcCtD
Trifluoperazine—Rash—Betamethasone—psoriatic arthritis	0.00103	0.00163	CcSEcCtD
Trifluoperazine—Rash—Dexamethasone—psoriatic arthritis	0.00103	0.00163	CcSEcCtD
Trifluoperazine—Dermatitis—Betamethasone—psoriatic arthritis	0.00103	0.00162	CcSEcCtD
Trifluoperazine—Dermatitis—Dexamethasone—psoriatic arthritis	0.00103	0.00162	CcSEcCtD
Trifluoperazine—Fatigue—Methotrexate—psoriatic arthritis	0.00102	0.00162	CcSEcCtD
Trifluoperazine—Headache—Betamethasone—psoriatic arthritis	0.00102	0.00162	CcSEcCtD
Trifluoperazine—Headache—Dexamethasone—psoriatic arthritis	0.00102	0.00162	CcSEcCtD
Trifluoperazine—Asthenia—Prednisone—psoriatic arthritis	0.00102	0.00161	CcSEcCtD
Trifluoperazine—Pruritus—Prednisone—psoriatic arthritis	0.001	0.00159	CcSEcCtD
Trifluoperazine—Nausea—Betamethasone—psoriatic arthritis	0.000968	0.00153	CcSEcCtD
Trifluoperazine—Nausea—Dexamethasone—psoriatic arthritis	0.000968	0.00153	CcSEcCtD
Trifluoperazine—Urticaria—Methotrexate—psoriatic arthritis	0.000942	0.00149	CcSEcCtD
Trifluoperazine—Dizziness—Prednisone—psoriatic arthritis	0.000938	0.00149	CcSEcCtD
Trifluoperazine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000937	0.00148	CcSEcCtD
Trifluoperazine—Rash—Prednisone—psoriatic arthritis	0.000895	0.00142	CcSEcCtD
Trifluoperazine—Dermatitis—Prednisone—psoriatic arthritis	0.000894	0.00142	CcSEcCtD
Trifluoperazine—Headache—Prednisone—psoriatic arthritis	0.000889	0.00141	CcSEcCtD
Trifluoperazine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000874	0.00138	CcSEcCtD
Trifluoperazine—Asthenia—Methotrexate—psoriatic arthritis	0.000851	0.00135	CcSEcCtD
Trifluoperazine—Nausea—Prednisone—psoriatic arthritis	0.000843	0.00133	CcSEcCtD
Trifluoperazine—Pruritus—Methotrexate—psoriatic arthritis	0.000839	0.00133	CcSEcCtD
Trifluoperazine—Dizziness—Methotrexate—psoriatic arthritis	0.000784	0.00124	CcSEcCtD
Trifluoperazine—Rash—Methotrexate—psoriatic arthritis	0.000748	0.00118	CcSEcCtD
Trifluoperazine—Dermatitis—Methotrexate—psoriatic arthritis	0.000747	0.00118	CcSEcCtD
Trifluoperazine—Headache—Methotrexate—psoriatic arthritis	0.000743	0.00118	CcSEcCtD
Trifluoperazine—Nausea—Methotrexate—psoriatic arthritis	0.000704	0.00112	CcSEcCtD
